How many insider trades does FilingIQ track for CNTB?

FilingIQ tracks 3 Form 4 insider transactions for CNTB (Connect Biopharma Holdings Ltd), covering filings from Mar 31, 2026 onwards. 3 of those were filed in the last 90 days.

Are CNTB insiders net buyers or net sellers?

Across the full Form 4 history for CNTB, 1 transactions (33%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CNTB insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CNTB in?

Connect Biopharma Holdings Ltd (CNTB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $152.06M.

CNTB insider trading

NasdaqGM Healthcare

Connect Biopharma Holdings Ltd — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

33% / 0%

Market cap

$152.06M

About Connect Biopharma Holdings Ltd

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.

Company website: www.connectbiopharm.com

CNTB insider activity at a glance

FilingIQ has scored 3 insider transactions for CNTB since Mar 31, 2026. The most recent filing in our index is dated Mar 31, 2026.

Across the full history, 1 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CNTB insider trades is 51.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CNTB trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for CNTB?: FilingIQ tracks 3 Form 4 insider transactions for CNTB (Connect Biopharma Holdings Ltd), covering filings from Mar 31, 2026 onwards. 3 of those were filed in the last 90 days.
Are CNTB insiders net buyers or net sellers?: Across the full Form 4 history for CNTB, 1 transactions (33%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CNTB insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CNTB in?: Connect Biopharma Holdings Ltd (CNTB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $152.06M.

Methodology & sources

Every CNTB insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.